Jaundice in newborns is a condition characterized by an increase in the level of bilirubin in the blood, which leads to yellowing of the skin and mucous membranes of the baby. Jaundice is quite common in newborns, and in most cases it occurs a few days after birth. The main cause of this condition is the immaturity of the baby's liver, which does not fully cope with the processing of bilirubin formed during the destruction of red blood cells. Jaundice in newborns can be physiological, resulting from natural processes, or pathological, associated with various diseases, such as hemolytic disease, infections, metabolic disorders, and others.
History of the disease and interesting historical facts
The history of neonatal jaundice can be traced back to ancient times. The first mentions of jaundice date back to ancient texts, which described cases of yellowing of the skin in infants. In the 18th century, doctors began to pay closer attention to this condition, which led to the first systematic observations and descriptions of its causes. One of the most famous cases of jaundice was the case of "yellow fever," which became the basis for the study of hemolytic processes in the body. In the 20th century, with the development of medicine and technology, it became possible to study in more detail the mechanisms of jaundice formation, which led to the identification of genetic predispositions and pathologies underlying the disease. It is noteworthy that in the early stages of disease research, doctors used animal models, which contributed to the understanding of physiological processes in humans.
Epidemiology
Epidemiological studies show that neonatal jaundice occurs in approximately 40% healthy term infants and up to 80% preterm infants. The incidence of jaundice may vary depending on the geographic region, perinatal care characteristics, and level of health services. In low birth weight infants, the incidence of jaundice reaches 90%. The incidence of pathological jaundice is highly dependent on genetic predisposition, as well as environmental factors, including the presence of infectious diseases and antigenic differences between mother and child. These data suggest the need to implement a monitoring system for the rapid detection and treatment of neonatal jaundice, which can reduce the risk of complications.
Genetic predisposition to this disease
Genetic predisposition to neonatal jaundice is often associated with certain genes and mutations. The most well-known of these are the genes responsible for the synthesis of enzymes involved in the metabolism of bilirubin. For example, mutations in the UGT1A1 gene, which codes for the enzyme uridyl glucuronosyltransferase, can lead to bilirubinemia. This condition is known as Crigler-Neidler syndrome. The frequency of mutations in this gene varies depending on the population: Africans, Europeans and Asians have different carrier rates of conditions that lead to jaundice. Hereditary factors should also be taken into account, since the risk of developing this disease is significantly increased in children whose parents had cases of jaundice.
Risk factors for the development of this disease
Risk factors for neonatal jaundice can be divided into several categories:
- Physical factors:
- Prematurity - Babies born before 37 weeks have a higher risk of jaundice.
- Low birth weight is associated with immaturity of organs, including the liver.
- Chemical factors:
- Hemolytic conditions - for example, Rh incompatibility.
- Poisoning or exposure to toxic substances - such as drugs that can negatively affect bilirubin metabolism.
- Other factors:
- Infections - viral or bacterial infections in the early neonatal period can cause jaundice.
- Developmental abnormalities - such as bile duct stenosis or problems with liver function.
Diagnosis of this disease
Diagnosis of neonatal jaundice involves several approaches:
- Main symptoms:
- Yellowing of the skin and mucous membranes.
- Enlargement of the liver and spleen.
- Changes in the color of urine and stool.
- Laboratory tests:
- Determination of bilirubin levels in the blood.
- Test for hemolysis (check hemoglobin levels, reticulocytes).
- Testing for infection, including serological tests.
- Radiological examinations:
- Ultrasound examination of the abdominal organs to assess the condition of the liver and bile ducts.
- Other types of diagnostics:
- Genetic testing for mutations associated with jaundice.
- Liver biopsy in rare cases if liver pathology is suspected.
- Differential diagnosis:
- Hemolytic disease of the newborn.
- Infections such as hepatitis.
- Genetic metabolic disorders.
Treatment
Treatment of neonatal jaundice depends on its nature and severity. In most cases, physiological jaundice requires observation and does not require active intervention, as it resolves on its own. The main treatment methods include:
- General treatment:
- Monitoring bilirubin levels, maintaining adequate hydration status.
- Correction of posture to improve venous outflow in a newborn at the observation stage.
- Pharmacological treatment:
- Use of phenobarbital - can be used in severe forms of jaundice.
- In the presence of infections, antibiotic therapy is administered as indicated.
- Surgical treatment:
- Correction of anatomical anomalies, if any, for example, in case of biliary stenosis.
- Other types of treatment:
- Phototherapy - used to reduce bilirubin levels using blue lamps.
- Contributing blood transfusions in acute and severe cases.
List of medications used to treat this disease
The following medications can be used to treat neonatal jaundice:
- Phenobarbital - helps reduce bilirubin levels.
- Antibiotics (as indicated) - to treat infections associated with jaundice.
- Mixtures for correction of metabolism (in case of metabolic disorders).
Disease monitoring
Monitoring of newborns with jaundice includes regular checks of bilirubin levels and clinical examinations. The following steps may be used for monitoring:
- The first examination is in the maternity hospital, after 24–48 hours, to determine the bilirubin level.
- Continuous monitoring on an outpatient basis, especially during the first week of life.
- Assess symptoms and bilirubin levels every 5–7 days for the first two weeks.
Age-related features of the disease
The course of jaundice in newborns can vary depending on age:
- In newborns, in the first days of life, there may be a sign of pathological jaundice, requiring surgical intervention.
- At the age of 1–2 weeks, physiological jaundice reaches its peak, but usually passes without complications.
- After 2 weeks, the manifestations and symptoms of jaundice should disappear; if not, pathological causes should be excluded.
Questions and Answers
- What are the causes of jaundice in newborns?
Answer: The causes may be physiological, associated with liver failure, or pathological, associated with hemolytic conditions and infections. - How is jaundice in newborns treated?
Answer: In most cases, physiological jaundice does not require treatment, but in severe cases, phototherapy and other methods may be used. - What are the main symptoms of neonatal jaundice?
Answer: The main symptoms include yellowing of the skin and mucous membranes, darkening of urine and discoloration of stool. - When should you see a doctor for newborn jaundice?
Answer: You should contact a doctor if jaundice appears in the first 24 hours after birth, as well as if the bilirubin level increases significantly. - Is it possible to prevent neonatal jaundice?
Answer: Physiological jaundice cannot be prevented, but adequate perinatal care and monitoring of the newborn's condition are important.
